fecal
specimen
n
patient
day
symptom
onset
urin
specimen
n
patient
day
symptom
onset
collect
sar
patient
hospit
hong
kong
march
may
sar
confirm
presenc
serum
immunoglobulin
ig
g
sarscov
immunofluoresc
assay
specimen
test
polyclon
monoclon
captur
elisa
sarscov
nucleocapsid
protein
realtim
qrtpcr
control
urin
n
fecal
n
specimen
obtain
hospit
patient
without
sar
sarscov
nucleocapsid
protein
detect
polyclon
elisa
accord
publish
protocol
sarscov
nucleocapsid
protein
detect
monoclon
elisa
use
modifi
protocol
serum
sampl
briefli
fecal
urin
specimen
inactiv
phenol
respect
min
centrifug
dilut
phosphatebuff
salin
skim
milk
one
hundr
microlit
dilut
fecal
specimen
dilut
urin
specimen
ad
well
previous
coat
antinucleocapsid
monoclon
antibodi
plate
incub
wash
treat
antinucleocapsid
rabbit
monoclon
antibodi
analyz
describ
previous
rna
extract
realtim
qpcr
assay
specif
region
sarscov
conduct
describ
previous
compar
detect
rate
elisa
realtim
qrtpcr
use
mcnemar
test
studi
correl
optic
densiti
valu
nm
elisa
viral
concentr
determin
realtim
qrtpcr
linear
regress
spss
version
spss
inc
chicago
il
usa
p
valu
regard
signific
comparison
elisa
shown
figur
tabl
cutoff
polyclon
elisa
determin
previous
specif
fecal
urin
specimen
respect
baselin
monoclon
elisa
determin
use
control
fecal
urin
specimen
mean
valu
standard
deviat
sd
valu
respect
specif
monoclon
elisa
fecal
specimen
urin
specimen
determin
use
cutoff
defin
mean
sd
fecal
sampl
obtain
sar
patient
obtain
day
onset
symptom
posit
polyclon
elisa
obtain
day
posit
monoclon
elisa
urin
sampl
obtain
day
onset
symptom
posit
polyclon
elisa
obtain
day
posit
monoclon
elisa
result
polyclon
elisa
compar
previou
data
differ
specimen
valu
fecal
pearson
correl
p
urin
specimen
pearson
correl
p
detect
elisa
significantli
correl
method
choic
earli
diagnosi
sarscov
infect
qrtpcr
sensit
qrtpcr
superior
elisa
moreov
qrtpcr
detect
sarscov
earlier
fecal
specimen
tabl
among
fecal
sampl
sar
patient
posit
qrtpcr
significantli
higher
polyclon
monoclon
antibodybas
elisa
mcnemar
test
p
p
respect
urin
sampl
sar
patient
posit
qrtpcr
also
significantli
higher
polyclon
monoclon
antibodybas
elisa
mcnemar
test
p
comparison
qrtpcr
use
standard
sensit
polyclon
monoclon
elisa
fecal
specimen
urin
specimen
respect
qrtpcr
detect
sarscov
fecal
specimen
obtain
day
onset
symptom
urin
specimen
obtain
day
moreov
fecal
specimen
obtain
day
posit
qrtpcr
test
highest
detect
rate
fecal
specimen
collect
day
suggest
period
peak
viral
shed
stool
detect
rate
urin
specimen
much
lower
fecal
specimen
assay
sarscov
detect
late
phase
ill
sinc
sarscov
readili
isol
sar
patient
week
ill
detect
sarscov
beyond
time
may
due
prolong
shed
nonviabl
virus
patient
presenc
neutral
immunoglobulin
clinic
specimen
prevent
viral
replic
cell
cultur
sarscov
rna
concentr
elisa
result
correl
higher
detect
rate
elisa
found
specimen
higher
viral
concentr
tabl
also
signific
correl
viral
load
elisa
valu
fecal
specimen
test
monoclon
elisa
pearson
correl
p
urin
specimen
test
polyclon
monoclon
elisa
pearson
correl
respect
p
analysi
although
correl
viral
load
elisa
valu
fecal
specimen
test
polyclon
elisa
signific
trend
correl
pearson
correl
p
studi
fecal
urin
sampl
use
easier
safer
obtain
readili
avail
previou
report
nucleocapsid
protein
detect
polyclon
elisa
nasopharyng
aspir
collect
day
symptom
onset
monoclon
elisa
serum
obtain
first
day
find
suggest
elisa
may
use
use
nasopharyng
aspir
serum
specimen
howev
specimen
includ
current
studi
small
amount
avail
similar
studi
conduct
sampl
avail
studi
support
research
grant
council
grant
hku
vicechancellor
sar
research
fund
univers
hong
kong
suen
chi
sun
charit
foundat
sar
research
fund
